Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)

HKG:1349 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-152.39	-157.44	39.73	108.63	138	213.3
Depreciation & Amortization	61.03	61.03	74.2	59.93	80.97	60.85
Other Amortization	17.62	17.62	8.02	2.3	1.22	0.96
Loss (Gain) From Sale of Assets	-0.22	-0.22	-0.03	-0.3	-1.92	-1.78
Asset Writedown & Restructuring Costs	0.35	0.35	4.42	5.78	1.01	0.35
Loss (Gain) From Sale of Investments	9.85	9.85	10.41	4.35	1.28	-20.76
Stock-Based Compensation	-	-	-	-1.84	7.69	64.97
Provision & Write-off of Bad Debts	-23.85	-23.85	-8.93	23.9	-2.41	5.78
Other Operating Activities	-16.79	1.8	2.49	6.23	-0.28	-6.13
Change in Accounts Receivable	213.27	213.27	114.05	-10.47	-89.73	-95.37
Change in Inventory	12.53	12.53	-5.86	-6.57	-5.84	0.32
Change in Accounts Payable	1.46	1.46	-236.31	-74.05	48.72	72.56
Change in Unearned Revenue	3.13	3.13	13.69	-31.89	-6.76	-9.89
Operating Cash Flow	127.86	141.4	-16.51	71.02	165.27	268.9
Operating Cash Flow Growth	-	-	-	-57.03%	-38.54%	137.96%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-32.97	-32.37	-42.67	-98.97	-87.3	-120.12
Sale of Property, Plant & Equipment	0.34	0.83	0.64	0.68	1.44	1.71
Divestitures	-	-	-	-	-	6.34
Investment in Securities	15.25	15.25	18.15	52.91	-10.88	-243.6
Other Investing Activities	285.15	4.08	1.74	-	-	-
Investing Cash Flow	267.77	-12.21	-22.14	-45.38	-96.75	-355.67

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	-	-	-	101	-
Total Debt Issued	-	-	-	-	101	-
Long-Term Debt Repaid	-	-6.81	-7.93	-109.38	-9.52	-7.5
Total Debt Repaid	-6.81	-6.81	-7.93	-109.38	-9.52	-7.5
Net Debt Issued (Repaid)	-6.81	-6.81	-7.93	-109.38	91.48	-7.5
Issuance of Common Stock	-	-	-	66.86	-	-
Repurchase of Common Stock	-	-	-	-	-8.7	-40.82
Common Dividends Paid	-31.1	-31.1	-93.29	-76.15	-71.04	-52.15
Other Financing Activities	0.61	-	-0.05	-0.31	-0.14	-0.69
Financing Cash Flow	-37.3	-37.91	-101.27	-118.98	11.61	-101.16

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.76	-0.49	0.32	-0.07	0.29	-0.07
Net Cash Flow	357.56	90.79	-139.61	-93.41	80.42	-188.01

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	94.88	109.03	-59.18	-27.95	77.96	148.78
Free Cash Flow Growth	-	-	-	-	-47.60%	110.76%
Free Cash Flow Margin	14.49%	15.90%	-8.34%	-3.29%	7.56%	13.05%
Free Cash Flow Per Share	0.09	0.10	-0.06	-0.03	0.08	0.14
Levered Free Cash Flow	139.28	153.42	-96.46	18.64	86.7	116.02
Unlevered Free Cash Flow	139.65	153.83	-96.09	20.56	87.67	116.68

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Income Tax Paid	52.98	49.54	49.21	33.53	68.66	68.12
Change in Working Capital	232.25	232.25	-146.83	-137.96	-60.29	-48.63

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 31, 2026

Data Sources Report a data error